Transglutaminase Type 2 Regulates ER-Mitochondria Contact Sites by Interacting with GRP75 by D'Eletto, M et al.
ReportTransglutaminase Type 2 Regulates ER-
Mitochondria Contact Sites by Interacting with
GRP75Graphical AbstractHighlightsd TG2 interacts with GRP75 in mitochondria-associated
membranes (MAMs)
d TG2 influences the number of ER-mitochondria contact sites
d TG2 regulates the interaction between IP3R3 and GRP75
d TG2 controls ER-mitochondrial Ca2+ flux and protein
expression in MAMsD’Eletto et al., 2018, Cell Reports 25, 3573–3581
December 26, 2018 ª 2018 The Authors.
https://doi.org/10.1016/j.celrep.2018.11.094Authors
Manuela D’Eletto, Federica Rossin,
Luca Occhigrossi, ..., Paolo Pinton,
Michelangelo Campanella,
Mauro Piacentini
Correspondence
mauro.piacentini@uniroma2.it
In Brief
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found that TG2 interacts with GRP75, a
protein localized in mitochondria-
associated membranes (MAMs). TG2
regulates the number of ER-mitochondria
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key regulatory role in MAMs.
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Transglutaminase type 2 (TG2) is a multifunctional
enzyme that plays a key role in mitochondria ho-
meostasis under stressful cellular conditions. TG2
interactome analysis reveals an enzyme interaction
with GRP75 (glucose-regulated protein 75). GRP75
localizes in mitochondria-associated membranes
(MAMs) and acts as a bridging molecule between
the two organelles by assembling the IP3R-GRP75-
VDAC complex, which is involved in the transport
of Ca2+ from the endoplasmic reticulum (ER) to mito-
chondria. We demonstrate that the TG2 and GRP75
interaction occurs in MAMs. The absence of the
TG2-GRP75 interaction leads to an increase of the
interaction between IP3R-3 and GRP75; a decrease
of the number of ER-mitochondria contact sites; an
impairment of the ER-mitochondrial Ca2+ flux; and
an altered profile of the MAM proteome. These
findings indicate TG2 is a key regulatory element
of the MAMs.INTRODUCTION
Transglutaminase type 2 (TG2) is themost ubiquitous member of
a large group of enzymes that catalyze the Ca2+-dependent
posttranslational modification of proteins, including protein-pro-
tein cross-linking, incorporation of primary amines into proteins,
and glutamine deamination (Piacentini et al., 2011). TG2 pos-
sessesmore than one catalytic function, and under physiological
conditions, the low cytosolic Ca2+concentration does not allow
the protein to act as a transamidating enzyme. TG2 can also
bind and hydrolyze GTP and acts as a G protein (Begg et al.,
2006). Moreover, it has also been reported that TG2 possessesCell Repo
This is an open access article under the CC BY-Nintracellular serine/threonine protein kinase and protein disulfide
isomerase (PDI) activity (Hasegawa et al., 2003).
The PDI activity of TG2 has been shown to lead to the post-
translational modification of key mitochondrial proteins, and
this activity is required for the proper assembly of the respira-
tory chain complexes (Altuntas et al., 2014). Furthermore, in
absence of TG2’s PDI activity, we observed an incorrect assem-
bly of mitochondrial ADP/ATP transporter adenine nucleotide
translocator 1 (ANT1) (Malorni et al., 2009). We have also
recently demonstrated that TG2 is involved in mitophagy,
particularly under stressful cellular conditions (Rossin et al.,
2014, 2015).
The analysis of TG2’s interactome has revealed that TG2 in-
teracts with several proteins belonging to different functional
categories, such as chaperones, mitochondrial proteins, meta-
bolic, and cytoskeletal (Altuntas et al., 2015; Diaz-Hidalgo et al.,
2016; D’Eletto et al., 2018). Among these, particularly interesting
is GRP75 (glucose-regulated protein75), also known as mor-
talin, a molecular chaperone belonging to the Hsp70 family
(Wadhwa et al., 1993a). Despite being predominantly localized
in the mitochondria, GRP75 has also been found in other sub-
cellular compartments (Wadhwa et al., 1993b). It has been
demonstrated that GRP75 tethers the N-terminal domain of
the IP3 receptors to VDAC1, generating a molecular bridge
that enhances the Ca2+ accumulation in mitochondria by stabi-
lizing conformations or the coupling of the two receptors (Sza-
badkai et al., 2006). The IP3R-GRP75-VDAC complex is present
at the ER-mitochondria interface, the so-called MAMs (mito-
chondria-associated membranes), where it plays a crucial role
in the regulation of the intracellular Ca2+ (Patergnani et al.,
2011). Basal Ca2+ oscillations drive mitochondrial metabolism
for the production of ATP and mitochondrial substrates used
in anabolic processes (Ca´rdenas et al., 2010). On the contrary,
mitochondrial Ca2+ overload can lead to mitochondrial perme-
ability transition pore opening and subsequent cell death (Riz-
zuto et al., 2012). Dysregulation of Ca2+ fluxes is involved inrts 25, 3573–3581, December 26, 2018 ª 2018 The Authors. 3573
C-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Figure 1. TG2 Interacts with GRP75 in the
MAMs
(A) Representative western blot analysis of TG2 and
GRP75 in HEK293TG2 cells subjected to immuno-
precipitation for TG2. After 24 hr of CCCP treatment,
cells were fractionated and crudemitochondrial (Mc)
and cytosolic (C) proteins were immunoprecipitated
using anti-TG2 antibody. Immunoprecipitated and
co-immunoprecipitated proteins were separated by
SDS-PAGE and immunoblotted using the indicated
antibodies. Crude mitochondrial and cytosolic ex-
tracts (INPUT) were used as protein control.
(B) Densitometric analysis of the ratio of co-immu-
noprecipitated GRP75/TG2 in crude mitochondrial
and cytosolic extracts. Data are mean ± SEM of
3 independent experiments (*p < 0.05; **p < 0.01).
(C) Subcellular distribution of TG2 and GRP75 in
crude mitochondria (Mc), mitochondria-associated
membrane (MAM), and pure mitochondria (Mp)
analyzed by western blot analysis. Marker proteins
indicate MAMs (SIGMAR1 and CNX) and pure
mitochondria (HSP60). All markers are present in the
crude mitochondria.
(D) Densitometric analysis of TG2 protein level in the
mitochondrial fractions. Data are mean ± SEM of
3 independent experiments (**p < 0.01).
(E and F) Immunoblotting analysis of TG2 and
GRP75 in HEK293TG2 (E) and WT MEF (F) cells
subjected to immunoprecipitation for TG2. The cells
were sub-fractionated and the MAM fractions were
immunoprecipitated using anti-TG2 antibody. CNX
was used as loading control for MAM extracts.several human disorders (Giorgi et al., 2018; Go´mez-Suaga
et al., 2018).
Considering the role that TG2 plays in mitochondrial homeo-
stasis as well as the involvement of GRP75 protein in ER-mito-
chondria Ca2+ transfer, we studied the interaction of TG2 and
GRP75 to shed light on the possible influence of TG2 in the ho-
meostasis of membrane contact sites between the ER and
mitochondria.
RESULTS
TG2 Interacts with GRP75 in the MAMs
To characterize the TG2’s binding partners, we have recently
performed the enzyme interactome analysis by utilizing the tan-
dem affinity purification approach combined with high-perfor-
mance liquid chromatography (HPLC) and MALDI TOF-TOF
mass spectrometry (Altuntas et al., 2015; Antonioli et al., 2017).
This analysis showed that TG2 interacts with several proteins
located in the endoplasmic reticulum (ER) and mitochondria
(Table S1). Among these, we focus our attention on the heat
shock 70 kDa protein 9B precursor, also known as GRP75.3574 Cell Reports 25, 3573–3581, December 26, 2018To confirm that TG2 interacts with
this putative novel partner, we analyzed
the interaction of the enzyme with
GRP75. To this aim, TG2 was immuno-
precipitated from HEK293 cells reconsti-
tuted with wild-type TG2 (HEK293TG2)(D’Eletto et al., 2012). In addition, considering that TG2 is
involved in the cellular response to mitochondrial stress (Rossin
et al., 2014), we treated HEK293TG2 cells with the mitochondrial
uncoupler carbonyl cyanide m-chlorophenyl hydrazine (CCCP)
for 24 hr. Data reported in Figures 1A and 1B reveal that the inter-
action between the two proteins occurred both in the crudemito-
chondrial fraction and in the cytosolic fraction. Interestingly, the
interaction of TG2 with GRP75 increases upon CCCP treatment
in crudemitochondrial fraction. This result was further confirmed
by co-immunoprecipitation of GRP75 in the crude mitochondrial
fraction (Figures S1A and S1B).
Considering that GRP75 plays an important role in MAM stabi-
lization (Szabadkai et al., 2006), we verified whether TG2 is pre-
sent in the MAMs. We performed the subcellular fractionation in
wild-type (WT) murine embryonic fibroblast (MEF) cells, and we
found that the TG2 present in the crude mitochondrial fraction
is localized exclusively at the MAMs, while it is undetectable in
the pure mitochondria (Figures 1C and 1D), thus indicating that
the interaction of TG2 with GRP75 occurs in the MAM fraction.
To verify this hypothesis, we immunoprecipitated TG2 from the
MAM protein fractions of HEK293TG2 cells and WT MEF (Figures
Figure 2. TG2 Influences the Interaction be-
tween IP3R-3 and GRP75
(A and C) Representative western blot analysis of
IP3R-3 and GRP75 in KO MEF, WT MEF, and KO
MEF mTG2 (A) and No target and shTG2 WT MEF
(C) subjected to immunoprecipitation for IP3R-3.
After 24 hr of CCCP treatment, cells were lysed, and
proteins were immunoprecipitated using anti-
IP3R-3 antibody. Immunoprecipitated and co-
immunoprecipitated proteins were separated by
SDS-PAGE and immunoblotted using the indicated
antibodies. INPUT, whole cell lysate, was used as
protein control.
(B and D) Densitometric analysis of the ratio of
co-immunoprecipitated GRP75/IP3R-3 in KO MEF,
WT MEF, and KO MEF mTG2 (B) and No target and
shTG2 WT MEF (D).
Data are mean ± SEM of 3 independent experi-
ments (**p < 0.01; ***p < 0.001).1E and 1F), and the data confirmed that the interaction specif-
ically occurs in the MAM region. Of note, we also confirmed
the presence of TG2 in the MAMs in vivo in the mouse liver
(Figure S2).
TG2 Regulates the Interaction between IP3R3 and
GRP75
It has been shown that GRP75 tethers the ligand-binding domain
of the IP3 receptors to VDAC1 (Szabadkai et al., 2006). In order to
verify whether TG2 could influence the regulation of this com-
plex, we analyzed the interaction of IP3R-3 with GRP75 in pres-
ence or absence of TG2. To this aim we co-immunoprecipitated
IP3R-3 in WT MEF, knockout (KO) MEF, and KO MEF overex-
pressing TG2 (KO MEF mTG2) (Figures S3A and S3B), in basal
condition and after CCCP treatment. As shown in Figures 2A
and 2B, in KO MEF there is an increase of IP3R-3-GRP75 inter-
action respect to WT MEF in basal condition. Interestingly, this
interaction decreases when TG2 was overexpressed, thus sug-
gesting that TG2 could play a role in modulating the functional
interaction between these two proteins. To confirm these results,
we repeated this experiment by ablating the TG2 in WT MEF us-
ing RNA interference (Figures S3C and S3D). The results clearly
show that the interaction between IP3R-3 and GRP75, in the
presence of TG2, decreases under basal conditions, whereas
no significant difference is observed after CCCP treatment (Fig-
ures 2C and 2D). These data indicate that the amount of GRP75
present in the IP3R-GRP75-VDAC complex is influenced by the
presence of TG2.
TG2 Influences the Number of MAMs
Physiological contacts between ER and mitochondria are
defined as involving distances of approximately 10–30 nm (Csor-
da´s et al., 2006). Such close connections are required to properly
facilitate Ca2+ and phospholipid exchange between the two
organelles. We used an in situ proximity ligation assay (PLA) to
detect and quantify the number of contact sites in presence orabsence of TG2. WT and KO MEFs were probed with anti-
IP3R-3 and anti-VDAC1 primary antibodies followed by hybridi-
zation with secondary antibodies coupled to different fluores-
cent oligonucleotides that hybridize if the distance between
two antibody-coupled oligonucleotides is < 40 nm. The analysis
of the fluorescence PLA signals (reds dots) showed that in
absence of TG2, there are less contact sites, indicating a
possible influence of the enzyme in the ER versus mitochondrial
membrane interactions (Figures 3A and 3B). We also evaluated
PLA signals after 6 hr of CCCP, a treatment known to induce
TG2 transamidating activity (Rossin et al., 2015). The analysis
of PLA dots after CCCP treatment revealed an increase in the
contact sites only in WT MEF (Figure S4A) that was lost after
the inhibition of TG2 activity by Z-DON-Val-Pro-Leu-OMe
(Z-DON) (Figure S4B) (D’Eletto et al., 2017). We have also
analyzed the ER-mitochondrial contact sites with live cell imag-
ing; to this aim the cells were double stained for the ER (green,
using ER-Tracker BODIPY) and mitochondria (red, using Mito-
Tracker) (Figure 3C), thus allowing the determination of the coef-
ficients of co-localization and overlap between the two signals.
The zoomed panel shows more ER-mitochondrial contacts in
WT compared to KO MEFs (Figure 3D). To further corroborate
these data, we performed transmission electron microscopy
(TEM) analysis in WT and KO liver. ER-outer mitochondrial
membrane (OMM) apposition was measured considering the
following three subsets of ER-OMM distances: closely associ-
ated < 30 nm, between 31 and 50 nm, and between 51 and
100 nm. Figures 3E and 3F clearly confirmed that in absence
of TG2 the distance between ER and mitochondria increased,
indicating an effective structural role of TG2 in the MAMs.
The Lack of TG2 Alters the Protein Expression in the
MAMs
TheMAMis asubdomain of theERactingasacentral organizer of
several metabolic processes, including calcium and apoptotic
signaling, synthesis of phospholipids, cholesterol trafficking,Cell Reports 25, 3573–3581, December 26, 2018 3575
(legend on next page)
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and inflammasome signaling (Sassano et al., 2017). Considering
the above reported results showing that TG2 is present in the
MAMs, where it plays an important structural role regulating the
number of contact sites, we decided to analyze whether TG2
could influence the MAM protein composition. As shown in Fig-
ure 4, the lack of TG2drastically changes the protein composition
in theMAMs. In fact the protein levels ofMfn2, TBK1, STING, Rab
32, and TSPO decreased in KO MEF with respect to WT MEF in
MAM fractions, indicating a possible role of TG2 in the proteome
in this region. Interestingly, hereweprovide the first evidence that
TSPO is present in theMAM fraction and its localization is strictly
TG2 dependent. It is interesting to note the selective increase in
the amount of GRP75 in the MAM fraction of KO MEF.
Effect of TG2 on Mitochondrial Ca2+ Uptake
Morphological changes in the mitochondrial network may be
linked to alterations in mitochondrial Ca2+ uptake pathways
(Gatliff et al., 2017). In order to obtain further insight regarding
the impact of TG2 on the Ca2+ transport efficiency between ER
and tethered mitochondria, Ca2+ uptake in the organelle was as-
sessed in cells with different levels of TG2 protein (Figure 5). To
do so, WT and TG2 overexpressing HEK293 were loaded with
fluorescent dyes and elicited via inositol triphosphate (IP3)
generating trigger ATP to induce, via the purinergic receptors,
mobilization of intracellulary stored Ca2+. The dynamic accumu-
lation of Ca2+ in the mitochondria was monitored via the Rhod-2
AM dye, which reported a faster and greater accumulation in
presence of forced TG2 expression (Figures 5A and 5B). The
analysis on the dynamics of Ca2+ was completed using WT
and KO MEFs. KO MEF showed a tangibly reduced response
when compared to conditions bearing normal TG2 level (Figures
5C and 5D). In these cells, the modulation of mitochondrial Ca2+
was corroborated further by using themitochondria-targeted ae-
quorin (mtAEQ) (Figures S5A and S5B). Interestingly, we also as-
sessed the effect of the TG2 inhibitor Z-DON on the dynamics
of mitochondrial Ca2+ uptake, which is reported in Figures 5E
and 5F. The dataset highlights the effective reduction of Ca2+
trafficking in the mitochondria operated by the inhibitor in com-
parison with untreated conditions. Z-DON treatment is thus
superimposable with the effect of TG2 ablation.
DISCUSSION
In this study, we demonstrated that TG2 localizes in the MAMs
and its presence in the ER-mitochondria contact site is essen-Figure 3. TG2 Affects the Number of Contact Sites
(A) Representative images of an in situ proximity ligation assay targeting IP3R-3
extent of the interaction. Nuclei were stained with DAPI. Each picture is represent
bar indicates 5 mm.
(B) Quantification of the PLA red fluorescent dots was performed using ImageJ.
(C) Live cell imaging using confocal microscopy of WT and KO MEFs, nuclei we
BODIPY (green), and mitochondria with MitoTracker Red (red).
(D) Quantification of the ER-mitochondria colocalization sites was performed usi
condition (n = 12–16 cells per coverslip of analysis; ****p < 0.0001).
(E and F) Ultrastructural analysis of ER-mitochondria contact (E). Representative
TG2mice. Higher magnifications highlight ER-OMMdistances. Quantification of th
distance categories (less than 30, between 31 and 50 nm, between 51 and 100 n
Bars represent mean ± SEM; n = 50 to 100 mitochondria in 10 fields per conditiotial to maintain the correct structural and functional homeosta-
sis of this important cellular regulatory site. We showed that
both the MAM proteome profile as well as the Ca2+ transport
are significantly affected in cells lacking TG2. In the absence
of TG2, there is both a decrease in the number and in the ar-
chitecture of contact sites between ER and mitochondria. In
fact, in the absence of TG2, the interaction between these
two organelles is largely modified as indicated by the tripli-
cated average distance between them. However, the absence
of the enzyme leads to an increased interaction of GRP75 with
the IP3R-3 complex. We speculate that this increase repre-
sents a compensatory attempt to maintain the contacts be-
tween these two organelles. This hypothesis is in line with
the increase in the amount of GRP75 detected in the MAM
fractions of KO MEF. These data are particularly interesting
in light of the fact that the transamidating activity of TG2 is
strictly dependent on Ca2+ (Tatsukawa et al., 2016). This is
relevant considering that the TG2’s biochemical activities
depend on its open versus closed 3D conformations, which
are regulated by the ratio of Ca2+ versus GTP levels, thus the
enzyme is able to modulate its own activity by regulating the
intracellular Ca2+ homeostasis. We show here that the inhibi-
tion of TG2 by Z-DON, which blocks the enzyme in the inactive
open conformation, is able to phenocopy the effects
observed in cells lacking the enzyme. This suggests that TG2
in its closed conformation participates in the regulation of the
ER-mitochondria contact site as a scaffold. Interestingly, after
mitophagy induction by CCCP, there is a specific activation
of TG2 transamidating activity on mitochondria, indicating
the TG2-dependent posttranslational modification of some
mitochondrial proteins upon mitochondrial damage (Rossin
et al., 2015).
TG2 plays an important regulatory role in key cellular function
such as apoptosis and autophagy. Both these events require the
tuning of the intracellular Ca2+ level and involve the homeostatic
control of mitochondria and the ER, respectively. In fact, exces-
sive uptake of Ca2+ by mitochondria can lead to opening of the
mitochondrial permeability transition pore and signaling for
apoptosis (Rizzuto et al., 2012).
The exquisite localization of TG2 in this cellular compartment
in which Ca2+ tonicity is particularly high may imply a core re-
distribution leading to maximize its activity and thus its impact
on cellular homeostasis. The cellular ability to handle stress
could be well influenced by the TG2 interplays with Ca2+ and
associated MAM resident mediators. Ablation of the enzyme-VDAC1 interactions of WT and KO MEFs. Red dots indicate the location and
ative of a typical cell staining observed in 10 fields chosen at random. The scale
Data are mean ± SEM of 4 distinct experiments (***p < 0.001).
re stained with Hoechst 33342 (blue), endoplasmic reticulum with ER-Tracker
ng ImageJ. Data represent mean ± SEM of 3 different sets of experiments per
TEM images of mitochondria (m) connected to the ER in liver from WT and KO
e relative amount of OMM in contact with the ER for each of the three ER-OMM
m) (F).
n (***p < 0.001).
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Figure 4. TG2’s Effect on the Protein Composition in
the MAMs
(A) Representative western blot analysis of chosen proteins in
KO and WT MEFs subjected to subcellular fractionation. The
cells were fractionated and cytosolic (C), crude mitochondrial
(Mc), and MAM proteins were separated by SDS-PAGE and
immunoblotted using the indicated antibodies. Tubulin was
used as loading control for cytosolic extract. CNX was used
as loading control for MAM proteins.
(B) Densitometric analysis of protein levels in MAM normal-
ized to CNX signal.
Data are mean ± SEM of 3 independent experiments
(*p < 0.05; **p < 0.01; ***p < 0.001).is matched by downregulation in the MAM region of the stress
response protein TSPO, which negatively regulates mitochon-
drial Ca2+ handling to fuel nicotinamide adenine dinucleotide
phosphate hydrogen (NADPH) oxidase production of free
radicals (Gatliff et al., 2017). Similarly, we demonstrated the
deregulation of MFN2 that regulates the ER morphology by
directly tethering the two organelles (de Brito and Scorrano,
2008). The TG2 ablation also leads to a downregulation of
Rab 32 in the MAMs where it participates in the control of
mitochondrial dynamics (Alto et al., 2002). It has been demon-
strated that endogenous and overexpressed Rab 32 localizes
to mitochondria and the MAMs in HeLa cells, where it modu-
lates MAM properties and apoptosis onset (Bui et al., 2010).3578 Cell Reports 25, 3573–3581, December 26, 2018Interestingly, recent reports have demonstrated
that cytoplasmic DNA released by microbes
and viruses can trigger double-stranded DNA
(dsDNA)-sensing pathways, which activate
STING (Ishikawa and Barber 2008). STING was
found to fractionate with MAMs and mitochondria
fractions and then signals to the TANK binding
kinase 1 (TBK1)-interferon regulatory factor-3
(IRF3) axis to upregulate type I interferon produc-
tion (Ishikawa et al., 2009). Both these protein
were downregulated in MAMs of TG2 lacking
cells, thus confirming the involvement of the
enzyme in the infectious diseases outcome (Pal-
ucci et al., 2018).
MAM contacts are also required for mitochon-
drial biogenesis because mitochondrial fission
occurs at these contact sites and are one of the
districts from which pre-autophagic vesicles are
generated (Lee and Yoon 2014; Hamasaki et al.,
2013). In keeping with this notion, it is important
to mention that TG2 is involved both in autophagy
and in mitophagy regulation, and its absence leads
to a large number of dysfunctional and fragmented
mitochondria with altered morphology and depo-
larization of the mitochondrial membrane (Rossin
et al., 2015; Piacentini et al., 2018).
These data open a new scenario in which TG2
may play a part also in the dynamic regulation of
MAMs and its contribution to cellular pathogenesis
(Pinton, 2018). On this basis, the data reported in
this study contribute to shedding light on the com-plex role played by TG2 in these essential cellular events under
normal and pathological settings.
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(A, C, and E) Representative traces of ATP-induced mito-
chondrial Ca2+ uptake in HEK293 (A) and MEFs (C and E). To
monitor intramitochondrial Ca2+ dynamics, cells were loaded
with the mitochondria-specific Ca2+ indicator Rhod-2 AM
(5 mM) and imaged using a confocal laser-scanning micro-
scope. Cells were challenged with ATP (100 mM) to induce
the purinoceptor-dependent emptying of the ERCa2+ stores.
Intramitochondrial Ca2+ dynamics analysis in WT and
KO MEFs in basal condition and after treatment with TG2
inhibitor (Z-DON) (E).
(B, D, and F) Bar charts of average Rhod-2 AM peak fluo-
rescence following administration of ATP in HEK293 (B) and
MEFs (D and F).
Data are mean ± SEM of 3 independent experiments
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EXPERIMENTAL MODEL AND SUBJECT DETAILS
Cell lines
WTand KOMEFs (murine embryonic fibroblasts) were obtained by spontaneous immortalization of fibroblasts derived fromC57BL/6
mice embryos either wild-type or knockout for TG2. HEK293TG2 stably reconstituted with the wild-type TG2, were obtained as pre-
viously described (D’Eletto et al., 2012). To silence TG2, WT MEF was stably transfected with pLKO.1 plasmid containing an shRNA
insert specific for TG2 (shTG2) or an shRNA insert that does not target any known genes from any species (no target shRNA) as
previously described (Rossin et al., 2018). MEFs, HEK293 and HEK293TG2 were cultured in Dulbecco’s modified Eagle’s medium
(Lonza) supplemented with 10% fetal bovine serum, 2 mM L-glutamine, 100 mg/ml streptomycin and 100 units/ml penicillin in a
5% CO2 incubator.
To induce mitochondrial damage MEF cells and HEK293 cells were incubated in full medium respectively with 20 mM and 10 mM
carbonyl cyanide m-chlorophenyl hydrazone (CCCP). TG2 transamidating activity was inhibited incubating the cells with 40 mM
Z-DON for 6 h.
Mice
All the procedures in mice were approved by the local Ethics Committee for Animal Welfare (Ministry of Health: 618/2015). Mice were
maintained under regular housing conditions with standard access to food and drink in a pathogen-free facility.
METHOD DETAILS
Cloning of Murine TG2 gene
TG2 cDNA was obtained by polymerase chain reaction (PCR) amplification using a murine muscle cDNA library derived from C2C7
total mRNA. The construct of WT murine TG2 gene was designed to be inserted into the EcoRI and NotI sites of the pLPCX vector
obtaining the pLPCX-mTG2 plasmid. The full length of murine TG2 gene was ligated into the EcoRI and NotI sites of the pLPCX
vector, which was transformed and sequenced to verify the amplification efficacy.
TG2 knockout reconstitution by retrovirus infection
pLPCX-mTG2 was transfected in the Bosc 23 ecotropic packaging line using CaCl2 and HBS to create high titer of ecotropic retro-
virus. After 48 h, the retroviral supernatant was harvested, filtered through a 0.45 mmmembrane and used to transduce KOMEF cells.
For the creation of cell lines, KOMEF cells were transduced by replacing the culture mediumwith retroviral conditionedmedium from
Bosc 23 ecotropic packaging cells, in the presence of 8 mg/ml Polybrene followed by incubation for 16–18 h at 37C. The culture
medium was replaced with fresh D-MEM, and cells were grown, trypsinized, replated, and selected for puromycin resistance usingCell Reports 25, 3573–3581.e1–e4, December 26, 2018 e2
the antibiotic added to the culture medium (2 mg/ml). We had previously performed a survival curve with the antibiotic on untrans-
fected cells to determine optimal antibiotic concentration and plating density.
Western blot analysis
Cells were collected in a lysis buffer containing 20 mM Tris-HCl pH 7.4, 150 mM NaCl and 1% Triton X-100 with protease inhibitor
cocktail (Roche). Proteins were quantified with standard Bradford staining and resolved on SDS-polyacrylamide gel and transferred
to a nitrocellulose membrane. Blots were blocked in 5% non-fat dry milk for 1 h at room temperature and then incubated overnight
with the primary antibodies. The membranes were incubated with HRP-conjugated secondary antibody for 1 h at room temperature
and the signal was detected by Immun-Star WesternC Kit (Bio-Rad Laboratories).
Subcellular fractionation
Subcellular fractionation was performed as previously described (Wieckowski et al., 2009). The procedure can be divided into 2main
steps. In the first, the cells were fractionated to obtain a crude mitochondrial fraction containing MAMs (denoted as crude mitochon-
dria, Mc). In the second, a further purification of crude mitochondria resulted in the isolation of highly purified mitochondria (denoted
as pure mitochondria, Mp) and MAMs.
All fractionation steps were carried out at 4C. The cells were homogenized and crude mitochondrial and microsomal fractions
were separated by differential centrifugation. Crude mitochondria was resuspended in the isolation buffer (250 mM mannitol,
5 mM HEPES, 0.5 mM EGTA, pH 7.4) and further separated on a 30% Percoll gradient to obtain low-density (MAM) and high-
density (Mp) fractions. Aliquots were collected and analyzed by immunoblotting.
Co-Immunoprecipitation (Co-IP)
Cells were lysed in IP buffer, containing 150 mM NaCl, 50 mM Tris HCl pH 7.5, 2 mM EDTA, 1% NP-40 and freshly added protease
inhibitor cocktail. An amount of 1.5 mg of proteins from cell lysates were subjected to immunoprecipitation using 2 mg of specific
antibodies in combination with 80 mL of Protein G PLUS–Agarose beads, overnight at 4C. LDS Sample Buffer 4 3 containing
2.86M 2-mercaptoethanol was added to beads and samples were boiled at 95C for 10min. Supernatants were analyzed bywestern
blot. Crude mitochondria were prepared by differential centrifugation: unbroken cells, nuclei and large membranes were removed
through a centrifugation at 500 g. The supernatant was further centrifugated at 9000 g. The pellet, which constituted the crude
mitochondrial fraction, was resuspended in IP buffer with protease inhibitor cocktail (Roche).
1 mg of mitochondrial proteins were subjected to immunoprecipitation using specific antibodies in a combination with Protein G
PLUS–Agarose. Immunoblot analysis was performed with indicated antibodies.
MAM fractions were purified and 500 mg of MAM proteins were subjected to immunoprecipitation using specific antibodies in a
combination with Protein G PLUS–Agarose. Immunoblot analysis was performed with indicated antibodies.
Proximity Ligation Assays (PLA)
Cells were cultured for 24 h on coverslips coated with Matrigel or Poly-Lysine and then fixed with 4% paraformaldehyde pH 7.4 in
PBS for 10 min at room temperature. Permeabilization was performed using 0.1% Triton X-100 in PBS for 10 min at room temper-
ature. Blocking was realized with 0.1% Triton X-100 in PBS with 5% BSA for 1h at room temperature. Incubations with primary
antibodies (VDAC1 and IP3R-3, 1:100 in 0.1% Triton X-100 in PBS with 5% BSA) were performed overnight at 4C in a humidity
chamber. Then, the cells were rinsed with Wash Buffer A. Next, PLUS and MINUS secondary PLA probes, both rabbit and mouse
immunoglobulins diluted in 0.1% Triton X-100 in PBS with 5% BSA, were added for 1 h at 37C. The incubation was followed by
5 min washes in two changes of Wash Buffer A. After this, the slides were incubated with the Duolink ligation mix for 30 min at
37C and thereafter washed with two changes of Wash Buffer A for 5 min each. The Duolink amplification mix was then applied
to the slides for 100 min at 37C. Subsequently, the slides were washed twice for 10 min each time with Wash Buffer B. Nuclei
were stained with DAPI and mounted on microscope slides, sealed with an anti-fading solution and examined under a Widefield
microscope Zeiss Axiovert 200M. Quantification of the PLA red fluorescent dots was performed using ImageJ, on 10 sets of images
acquired with the same optical settings and excluding the consideration of autofluorescence.
Transmission electron ultrastructural analysis
Liver samples were fixed with 2.5% glutaraldehyde in 0.1 M cacodylate buffer for 1 h at 4C, and postfixed in 1% osmium tetroxide in
0.1 M cacodylate buffer. Samples were then dehydrated in graded ethanol and embedded in Epon resin. For ultrastructural analysis
thin sections were stained with 2% uranyl acetate and observed under a Zeiss EM900 transmission electron microscope. Images
were captured digitally with a Mega View II digital camera (SIS, Soft Imaging System GmbH, Munster, Germany).
The circumference of mitochondria, and the proportions of the mitochondrial outer membrane (OMM) associated with ER, were
measured on the images using an image-processing software (analySIS 3.1; SIS). ER-OMM distance was measured considering
three subsets of ER-OMMdistances: closely associated (< 30 nm); between 31 and 50 nm; between 51 and 100 nm. Per each subset
quantitation of the ER length adjacent to mitochondria was calculated and normalized by mitochondrial perimeter.e3 Cell Reports 25, 3573–3581.e1–e4, December 26, 2018
Ca2+ signaling analysis
Mitochondrial Ca2+ dynamics were monitored live in WT and KO MEFs and in HEK293 and HEK293TG2 cells with the fluorescent
Ca2+-indicator Rhod-2, AM. To monitor Ca2+ dynamics, 1 x105 cells were seeded on 22 mm round borosilicate cover glasses in
6-well plates. Mitochondrial Ca2+dynamics were imaged by loading cells with 5 mM Rhod-2, AM in mHBSS supplemented with
0.005% Pluronic F-127 for 45 min at 37C. After four washes with mHBSS, cells were further incubated at 37C for 30 min to
enhance mitochondrial uptake following de-esterification of the dye. Cover glasses were then mounted inside an Attofluor cell
chamber and bathed in mHBSS and the image acquisition was performed using a Leica TCS SP5 confocal laser/scanning micro-
scope. Rhod-2 was excited with an Argon laser (514 nm) and laser power was kept between 1/5% to minimize photodamage.
100 mM ATP was used to induce Ca2+ release form the ER-stores. 15-25 cells were imaged in each experiment.
Aequorin measurements were performed as described (Bonora et al., 2013).
Imaging analysis of ER-mitochondria proximity
WT and KO MEFs were grown in DMEM containing penicillin-streptomycin and 10% FBS. 24 hours before imaging cells were
passaged and plated on Nunc Lab-Tek Chambered Coverglass (Thermo Fisher 155361). Cells were incubated in growth media
containing 20 nM MitoTracker and 100 nM ER-Tracker Green for 20 minutes at 37C, from stocks prepared as per manufacturer’s
instructions. Cells were washed twice (5minutes) with Live Cell Imaging Solution and then imaged in the same. Confocal imaging was
performed using LEICA SP-5 invertedmicroscope using a 60x oil objective in a warm 37C chamber. Images were acquired using the
Leica LAS software and analyzed using ImageJ for co-localization. Merged images created from intensity normalized scans were
thresholded to pick ‘yellow spots’ of colocalization; indicating ER-mitochondrial proximity.
QUANTIFICATION AND STATISTICAL ANALYSIS
Statistical details are provided in the figure legends. GraphPad Prism was used for statistical analysis. Image J64 software was used
for densitometric analysis. Statistical significance was determined using the Student’s t test or one-way ANOVA test. P value smaller
than 0.05 (p < 0.05) was considered to be significant.Cell Reports 25, 3573–3581.e1–e4, December 26, 2018 e4
